HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 319.20
Day range
kr 310.60 - kr 323.80
Year range
kr 238.20 - kr 547.00
Market cap
10.12B SEK
Avg Volume
205.07K
P/E ratio
74.31
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 218.59M | 17.51% |
Operating expense | 133.81M | 15.24% |
Net income | -12.40M | -154.42% |
Net profit margin | -5.67 | — |
Earnings per share | -0.30 | -140.55% |
EBITDA | 37.87M | 32.67% |
Effective tax rate | 11.76% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.87M | -38.20% |
Total assets | 2.30B | 1.84% |
Total liabilities | 202.68M | -19.10% |
Total equity | 2.09B | — |
Shares outstanding | 31.50M | — |
Price to book | 4.81 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -12.40M | -154.42% |
Cash from operations | -15.25M | -1,058.58% |
Cash from investing | -58.94M | -38.70% |
Cash from financing | -3.00M | -26.56% |
Net change in cash | -99.65M | -185.24% |
Free cash flow | -18.76M | -260.92% |
About
Founded
1998
Website
Employees
193
